Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-06-06

Clinical Trial Update: Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy

View source ↗

Summary

A clinical trial evaluating forskolin for lowering intraocular pressure in patients with primary open-angle glaucoma on maximum tolerated medical therapy has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forskolin (forskolin)

Snippet

Sponsor: Sooft Italia | Conditions: Primary Open Angle Glaucoma, Intraocular Pressure | Status: WITHDRAWN